Excaliard Pharmaceuticals Inc.


CARLSBAD, California, January 10, 2011 - Excaliard Pharmaceuticals, Inc., today announced results from three Phase 2 clinical trials of EXC 001 in skin scarring.
Older News
S M T W T F S
26 27 28 29 30 31 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
Copyright© 2011 The Gaea Times